Fisher & Paykel Healthcare (NZE:FPH, ASX:FPH) provided revenue and net profit guidance of NZ$1.08 billion and NZ$200 million, respectively, for the first half of fiscal 2026, according to a Thursday filing with the New Zealand and Australian bourses.
The guidance indicates a 13% increase in reported operating revenue and a 31% growth in reported net profit after tax compared with the first half of fiscal 2025, the filing said.
The company's fiscal 2026 outlook remains unchanged, with operating revenue in the range of NZ$2.15 billion to NZ$2.25 billion and net profit of between NZ$390 million and NZ$440 million, per the filing.
Shares rose 1% in Australian morning trade and nearly 2% in NZ afternoon trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.